Evidence map›Paper›PMID 33722860›Full record

ArticleGut2021

Blue poo: impact of gut transit time on the gut microbiome using a novel marker.

Francesco Asnicar, Emily R Leeming, Eirini Dimidi, Mohsen Mazidi, Paul W Franks, Haya Al Khatib, Ana M Valdes, Richard Davies, Elco Bakker, Lucy Francis and 7 more

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Gut, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 126 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 2 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03479866 naunknown statusnot on this map

Predicting Inter-individual Differences in Biochemical and Behavioral Response to Meals With Different Nutritional Compositions Using Metabolomic and Microbiome Profiling.

TypeinterventionalSponsorGuy's and St Thomas' NHS Foundation TrustRan2018 to 2023Enrolled2,500ConditionsDiabetes, Heart Diseases, Diet Habit, Diet ModificationArmsDietary intervention
NCT06340217 narecruitingnot on this mapstarted 2024, after this paper: background citation

The Efficacy and Safety of WMT in the Treatment of Diabetic Gastroparesis: A Multicenter, Randomized, Double-blind, Placebo-controlled Study

TypeinterventionalSponsorThe Second Hospital of Nanjing Medical UniversityRan2024 to 2029Enrolled46ConditionsDiabetic GastroparesisArmswashed microbiota transplantation, placebo
3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 2 syntheses or guidelines pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Roles of the gut microbiome in weight management.Nature reviews. Microbiology · 2023
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Francesco Asnicar *Department Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Emily R Leeming *Twins Research and Epidemiology, King's College London, London, UK.ORCID 0000-0002-0531-4901
Eirini Dimidi *Diabetes and Nutritional Sciences Division, King's College London, London, UK.
Mohsen MazidiTwins Research and Epidemiology, King's College London, London, UK.
Paul W FranksDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Haya Al KhatibDiabetes and Nutritional Sciences Division, King's College London, London, UK.
Ana M ValdesNIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals Trust and the University of Nottingham, Nottingham, UK.
Richard DaviesZoe Global, London, UK.ORCID 0000-0003-2050-3994
Elco BakkerZoe Global, London, UK.
Lucy FrancisZoe Global, London, UK.
Andrew ChanClinical and Translational Epidemiology Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Rachel GibsonDiabetes and Nutritional Sciences Division, King's College London, London, UK.
George HadjigeorgiouZoe Global, London, UK.
Jonathan WolfZoe Global, London, UK.
Timothy D SpectorDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Nicola SegataDepartment CIBIO, University of Trento, Trento, Trentino-Alto Adige, Italy.
Sarah E BerryDiabetes and Nutritional Sciences Division, King's College London, London, UK sarah.e.berry@kcl.ac.uk.
King's College London · GBZOE (United Kingdom) · GBUniversity of Trento · ITLund University · SEMassachusetts General Hospital · USUniversity of Nottingham · GB

Funding

Exploiting Public Metagenomic Data to Uncover Cancer-Microbiome RelationshipsR01CA230551 · NCI · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI Levi Waldron · 2020 to 2026
$3.9M
Exploiting public metagenomic data to uncover cancer-microbiome relationshipsU01CA230551 · NCI · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI WALDRON, LEVI · 2019 to 2019
$464k
Medical Research Council MR/N01183X/1Medical Research Council MR/N030125/1NCI NIH HHS R01 CA230551NCI NIH HHS U01 CA230551Wellcome Trust
6 · The paper itself

Abstract

BACKGROUND AND

aimsGut transit time is a key modulator of host-microbiome interactions, yet this is often overlooked, partly because reliable methods are typically expensive or burdensome. The aim of this single-arm, single-blinded intervention study is to assess (1) the relationship between gut transit time and the human gut microbiome, and (2) the utility of the 'blue dye' method as an inexpensive and scalable technique to measure transit time.

methodsWe assessed interactions between the taxonomic and functional potential profiles of the gut microbiome (profiled via shotgun metagenomic sequencing), gut transit time (measured via the blue dye method), cardiometabolic health and diet in 863 healthy individuals from the PREDICT 1 study.

resultsWe found that gut microbiome taxonomic composition can accurately discriminate between gut transit time classes (0.82 area under the receiver operating characteristic curve) and longer gut transit time is linked with specific microbial species such as

conclusionsGut transit time, measured via the blue dye method, is a more informative marker of gut microbiome function than traditional measures of stool consistency and frequency. The blue dye method can be applied in large-scale epidemiological studies to advance diet-microbiome-health research. Clinical trial registry website https://clinicaltrials.gov/ct2/show/NCT03479866 and trial number NCT03479866.

Indexed as

Gastrointestinal TransitAdultAkkermansiaBacteroidesBacteroidetesBiomarkersColoring AgentsFecesFemaleGastrointestinal MicrobiomeHumansMaleMetagenomicsMiddle AgedBiomarkersColoring Agentsgastrointestinal transitintestinal bacteria

Identifiers

PMID33722860
PMCPMC8349893
OpenAlexW3137887804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.